|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
Novadaq Novadaq Ranks High in Profit’s 100 Top Growth Companies
Novadaq Novadaq Ranks High in Profit’s 100 Top Growth Companies
Novadaq Ranks High in Profit’s 100 Top Growth Companies
Wednesday, 10 June 2009 02:47 | 
| Company News - Novadaq |
Novadaq Technologies Inc. announced it was ranked High in Profit’s among the 100 Top Growth Companies
Novadaq Technologies Inc. (TSX: NDQ), a developer of real-time imaging systems for use in the operating room, announced it was ranked 14th among the top 100 Fastest Growing Canadian Companies in Profit magazine's June publication of Profit 100: Your Guide to Business Success. Ranking Canada's Fastest-Growing Companies by five-year revenue growth, PROFIT 100 is Canada's largest annual celebration of entrepreneurial achievement. Novadaq is the only medical technology developer to be named among the top 15.
"The impact of SPY is well aligned with the U.S. government's healthcare reform agenda of improving quality and safety in a cost effective manner," said Dr. Arun Menawat, President and CEO of Novadaq. "To be ranked in 14th place confirms that we are making positive progress."
About PROFIT Magazine
PROFIT: Your Guide to Business Success, is Canada's preeminent publication dedicated to the management issues and opportunities facing small and mid-sized businesses. For more than 25 years, Canadian entrepreneurs across a vast array of economic sectors have remained loyal to PROFIT because it's a timely and reliable source of actionable information that helps them increase their revenues, boost their profitability and get the recognition they deserve for generating positive economic and social change. Published six times a year by Rogers Publishing Ltd., PROFIT is distributed almost exclusively to the chief executives of companies with 5 to 250 employees and annual revenue of $1 million to $25 million, reaching 306,000 readers across Canada. Visit PROFIT online at http://www.PROFITmagazine.ca.
About Novadaq Technologies Inc.
Novadaq develops and commercializes real-time imaging systems for use in the operating room. Novadaq's SPY® Imaging System uniquely enables surgeons to visualize blood vessels, tumors, tumor margins, blood flow and the lymphatic system in real-time during surgery. This core technology is now being applied across multiple surgical markets such as cardiac, plastic and reconstructive, urological, general, micro and transplant. The PINPOINTTM System for endoscopic autofluorescence imaging is Novadaq's first minimally invasive product. PINPOINT allows surgeons to differentiate between healthy and cancerous tissue in the lung and other hollow organs. To expand its portfolio of minimally invasive products, Novadaq is developing SPY scope which combines the typical features of a standard endoscope with the capabilities of SPY Imaging. The ability to visualize tissue perfusion and flow through vessels, ducts and the lymphatic system adds another dimension to the images available to surgeons during endoscopic surgical procedures. Novadaq also leverages its core technology to offer the OPTTX System, which is designed for the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD). Novadaq is the exclusive United States distributor of PLC Medical's CO2 HEART LASERTM System, which is used in the same cardiac procedures as the SPY Imaging System. For more information, please visit the company's website at http://www.novadaq.com.
Source: Novadaq Technologies Inc.
Novadaq Technologies Inc. (TSX: NDQ), a developer of real-time imaging systems for use in the operating room, announced it was ranked 14th among the top 100 Fastest Growing Canadian Companies in Profit magazine's June publication of Profit 100: Your Guide to Business Success. Ranking Canada's Fastest-Growing Companies by five-year revenue growth, PROFIT 100 is Canada's largest annual celebration of entrepreneurial achievement. Novadaq is the only medical technology developer to be named among the top 15.
"The impact of SPY is well aligned with the U.S. government's healthcare reform agenda of improving quality and safety in a cost effective manner," said Dr. Arun Menawat, President and CEO of Novadaq. "To be ranked in 14th place confirms that we are making positive progress."
About PROFIT Magazine
PROFIT: Your Guide to Business Success, is Canada's preeminent publication dedicated to the management issues and opportunities facing small and mid-sized businesses. For more than 25 years, Canadian entrepreneurs across a vast array of economic sectors have remained loyal to PROFIT because it's a timely and reliable source of actionable information that helps them increase their revenues, boost their profitability and get the recognition they deserve for generating positive economic and social change. Published six times a year by Rogers Publishing Ltd., PROFIT is distributed almost exclusively to the chief executives of companies with 5 to 250 employees and annual revenue of $1 million to $25 million, reaching 306,000 readers across Canada. Visit PROFIT online at http://www.PROFITmagazine.ca.
About Novadaq Technologies Inc.
Novadaq develops and commercializes real-time imaging systems for use in the operating room. Novadaq's SPY® Imaging System uniquely enables surgeons to visualize blood vessels, tumors, tumor margins, blood flow and the lymphatic system in real-time during surgery. This core technology is now being applied across multiple surgical markets such as cardiac, plastic and reconstructive, urological, general, micro and transplant. The PINPOINTTM System for endoscopic autofluorescence imaging is Novadaq's first minimally invasive product. PINPOINT allows surgeons to differentiate between healthy and cancerous tissue in the lung and other hollow organs. To expand its portfolio of minimally invasive products, Novadaq is developing SPY scope which combines the typical features of a standard endoscope with the capabilities of SPY Imaging. The ability to visualize tissue perfusion and flow through vessels, ducts and the lymphatic system adds another dimension to the images available to surgeons during endoscopic surgical procedures. Novadaq also leverages its core technology to offer the OPTTX System, which is designed for the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD). Novadaq is the exclusive United States distributor of PLC Medical's CO2 HEART LASERTM System, which is used in the same cardiac procedures as the SPY Imaging System. For more information, please visit the company's website at http://www.novadaq.com.
Source: Novadaq Technologies Inc.
